Status:
COMPLETED
Tissue Resistivity in Breast Cancer Patients
Lead Sponsor:
Ente Ospedaliero Cantonale, Bellinzona
Collaborating Sponsors:
Politecnico di Milano
Clinical Trial Unit Ente Ospedaliero Cantonale
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The resistivity measurements will be done by introducing a needle-probe into fresh healthy, peritumoral, and tumoral ex vivo tissues.
Detailed Description
Patients affected by breast cancer will have their tissue analysed immediately following their surgical excision for the treatment of breast cancer. Two probes will be used: a linear probe of 4 needle...
Eligibility Criteria
Inclusion
- Age \>18 years
- First radiological diagnosis of breast adenocarcinoma needing a histological confirmation
- Written Informed Consent
Exclusion
- Tumor mass diameter \< 1 cm
- Surgical specimen (harbouring tumoral + peritumoral tissue) diameter \< 2 cm
Key Trial Info
Start Date :
December 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2019
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03402997
Start Date
December 15 2017
End Date
September 25 2019
Last Update
December 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Regionale di Mendrisio
Mendrisio, Switzerland, 6850